Disease-Modifying Therapies Do Not Increase Cancer Risk in Multiple Sclerosis
-
The Relationship Between NMOSD and Cognitive Dysfunction InvestigatedGiven that NMOSD is associated with cognitive dysfunction, adequate support should be offered to decrease its impact on HRQoL.
-
Patients May Benefit From Focus on Their Experience in Long-Term HD CarePatient-centered care is increasingly relevant in the care of patients with long-term neurological conditions such as Huntington disease.
-
Examining the Role of Viral Infections in the Pathophysiology of Multiple SclerosisSome viral infections have been implicating in either driving the pathophysiology of multiple sclerosis or making it worse.
-
The Impact of Diet on Multiple Sclerosis Outcomes ExploredScientists have discovered that dietary choices can impact the pathophysiology of multiple sclerosis and its progression.
-
Rare Case of MS Followed By NMOSD ReportedA 57-year-old female with stable multiple sclerosis suddenly presented with symptoms of neuromyelitis optica spectrum disorder.
-
Cell-Based Therapies Show Potential to Promote Repair in Multiple SclerosisSeveral treatment options are available for multiple sclerosis, but none of them promote repair.
-
The Increased Risk of Multiple Sclerosis Faced by Black WomenWe Are Ill was started by influencer Victoria Reese, who was diagnosed with relapsing-remitting MS after having pain in her legs.
-
Medical Cannabis Gains Increasing Acceptance for Relieving MS SymptomsGrowing evidence suggests that the endocannabinoids in Cannabis sativa are especially effective in treating spasticity in patients with MS.
-
Families Struggle With Devastating Effects of Lambert-Eaton Myasthenic SyndromeLambert-Eaton myasthenic syndrome is extremely rare, with a global prevalence of only 2.8 per million, and just 400 known cases in the US.
-
The Unparalleled Potential of AI in Rare Disease Research and TreatmentThe US Food and Drug Administration has received hundreds of applications incorporating AI or machine learning in drug development.
-
MS Is Giving Me Pain in My HipColumnist with multiple sclerosis (MS) examines his recent hip and leg pain to parse out the cause and possible ways to eliminate pain.January 31, 2025
-
Potential MS Therapeutic Tolebrutinib Gets Boost From the FDATolebrutinib, a BTKi experimental therapy for multiple sclerosis (MS) is a step closer to US Food and Drug Administration (FDA) approval.January 6, 2025
-
The Check-Out Aisle ChallengeColumnist with multiple sclerosis (MS) confronts common barriers to accessibility and celebrates some simple solutions that make life easier.December 6, 2024
-
MS Medication Costs Keep ClimbingColumnist with multiple sclerosis (MS) discusses how rising drug costs affect people with MS, recommending a few ways to handle the problem.November 27, 2024